Search for: "Eli, Inc."
Results 901 - 920
of 999
Sorted by Relevance
|
Sort by Date
21 Jun 2012, 4:30 am
Eli Lilly, 2011 U.S. [read post]
26 Aug 2015, 2:15 pm
With increased activity regarding proposed federal trade secrets legislation expected next month and for the remainder of the fall Congressional session, Seyfarth Shaw’s dedicated Trade Secrets/Non-Compete group has created a resource which summarizes the proposed legislation, outlines the arguments in favor of and against the legislation, and provides additional resources for our readers’ convenience. [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
3 Jun 2010, 1:37 pm
Eli Lilly & Co., 854 N.E.2d 372 (Ind. [read post]
31 Aug 2020, 3:00 pm
Amtrust Financial Services Inc. in the U.S. [read post]
26 Feb 2021, 6:06 pm
Harvard Student Agencies, Inc. [read post]
8 Jan 2020, 2:43 pm
Harvard Student Agencies, Inc. [read post]
26 May 2015, 7:42 am
Recently, Bexis attended the DRI drug and device committee spring conference. [read post]
15 Jun 2024, 6:31 am
Kovacs are Directors at Innisfree M&A Inc. [read post]
15 Jun 2024, 6:31 am
Kovacs are Directors at Innisfree M&A Inc. [read post]
1 May 2008, 11:21 am
Beretta USA, Inc., No. 05-6942-cv (2d Cir. [read post]
26 Nov 2007, 7:49 am
Box 308 Faribault, MN 55021-0308 Phone: (507) 332-5491 (V/TTY); (800) 657-3936 (V/TTY/Toll Free) DEAF, Inc. 413 Wacouta Street Suite 300 St. [read post]
2 Jun 2014, 4:43 am
Cephalon, Inc., No. 13-7167, 2014 U.S. [read post]
8 May 2008, 12:22 pm
Pfizer Inc., 358 F.3d 659 (9th Cir. 2004). [read post]
3 May 2014, 8:56 am
Pfizer, Inc., 196 F. [read post]
18 Dec 2008, 10:36 pm
Eli Lilly & Co., 99 F.R.D. 126, 128 (D.D.C. 1983)). [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
12 Jun 2023, 1:09 pm
In Matrixx Initiatives, Inc. v. [read post]
13 Feb 2023, 7:28 am
’”Eli Velasquez, Founder & Managing Partner at Investors of Color Network, responding to questions posed by Rep. [read post]
3 Feb 2016, 7:16 am
The opinion goes on to explain that,[r]elying on the best evidence rule, Gauger lodged objections at trial to the introduction of two exhibits containing copies of three O'Reilly receipts and an exhibit containing a copy of a monthly invoice from O'Reilly. [read post]
